MARKET

JAZZ

JAZZ

Jazz Pharmaceuticals Plc
NASDAQ
188.69
+2.02
+1.08%
After Hours: 186.00 -2.69 -1.43% 19:05 03/04 EST
OPEN
186.93
PREV CLOSE
186.67
HIGH
190.67
LOW
184.15
VOLUME
885.31K
TURNOVER
--
52 WEEK HIGH
198.00
52 WEEK LOW
95.49
MARKET CAP
11.62B
P/E (TTM)
-31.0872
1D
5D
1M
3M
1Y
5Y
1D
Is Jazz Pharmaceuticals (JAZZ) Still Attractive After A 36% One Year Share Price Jump
Simply Wall St · 1d ago
Top Jazz Pharmaceuticals Insiders Quietly Unload Millions in Company Stock
TipRanks · 2d ago
Jazz Pharmaceuticals Balances Record Gains With Slower 2026
TipRanks · 2d ago
Jazz Pharmaceuticals Director Norbert G Riedel Disposes of Ordinary Shares
Reuters · 2d ago
Jazz EVP and Chief Legal Officer Neena M Patil Disposes of Common Shares
Reuters · 2d ago
Zymeworks Secures $250 Million Royalty-Backed Note Financing From Royalty Pharma
Reuters · 2d ago
Weekly Report: what happened at JAZZ last week (0223-0227)?
Weekly Report · 2d ago
Jazz Pharmaceuticals (JAZZ) Is Up 10.4% After Record Q4 Revenue And New Oncology Data Release
Simply Wall St · 4d ago
More
About JAZZ
Jazz Pharmaceuticals plc is a global biopharmaceutical company. It is engaged in developing medicines for people with serious diseases, often with limited or no therapeutic options. It has a diverse portfolio of marketed medicines, including therapies for sleep disorders and epilepsy, and a portfolio of cancer treatments. Its lead-marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Ziihera (zanidatamab-hrii), and Enrylaze (recombinant crisantaspase). Its product candidates include Zanidatamab, Vyxeos, JZP815, JZP898, JZP441, and others. Xywav is used for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy. The Company, through Chimerix, Inc., also owns a clinical asset, dordaviprone, a novel small molecule treatment in development for H3 K27M-mutant diffuse glioma.

Webull offers Jazz Pharmaceuticals PLC stock information, including NASDAQ: JAZZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAZZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAZZ stock methods without spending real money on the virtual paper trading platform.